What does this TikTok actually claim?
The video lists several "research peptides studied in autoimmune diseases" without naming specific compounds or conditions. @biohackingdudeforever promises to DM clinical papers and includes standard disclaimers about FDA approval and consulting doctors.
The creator positions this as educational content based on "clinical research" but doesn't specify which peptides or what the studies found. The hashtags suggest these compounds could lead to "autoimmune remission."
What peptides are actually being studied for autoimmune conditions?
A few peptides have legitimate research in autoimmune contexts, though most studies are preliminary. BPC-157 showed anti-inflammatory effects in rat models of inflammatory bowel disease (Sikiric et al., World J Gastroenterol, 2020).
Thymosin alpha-1 has been tested in small human trials for autoimmune hepatitis and multiple sclerosis. A 2019 study (Li et al., Autoimmun Rev) found modest improvements in 24 patients with autoimmune hepatitis over 48 weeks.
GHK-Cu demonstrated anti-inflammatory properties in cell culture studies, but human autoimmune trials are essentially nonexistent. Most "research" exists only in animal models or test tubes.
What's missing from this video?
The creator doesn't name a single specific peptide or study, making verification impossible. This is a red flag for any health claim.
The video also ignores that peptide research for autoimmune diseases is extremely early-stage. No peptides are FDA-approved for autoimmune conditions, and most human data comes from tiny pilot studies with significant limitations.
The hashtag #autoimmuneremission is particularly problematic since it suggests these compounds could eliminate autoimmune diseases. No current evidence supports this claim for any research peptide.
What should you know about peptides and autoimmune diseases?
Most peptides marketed as "research compounds" aren't actually being researched for the conditions people use them for. The regulatory gray area around these substances means quality and dosing vary wildly.
Autoimmune diseases require evidence-based treatment with medications that have undergone rigorous clinical trials. DMARDs, biologics, and other proven therapies have decades of safety and efficacy data.
If you're interested in experimental treatments, clinical trials offer the safest path. ClinicalTrials.gov lists legitimate studies testing new approaches to autoimmune conditions with proper oversight and monitoring.